Literature DB >> 8631908

Vitamin D receptors repress basal transcription and exert dominant negative activity on triiodothyronine-mediated transcriptional activity.

P M Yen1, Y Liu, A Sugawara, W W Chin.   

Abstract

We have examined vitamin D receptor (VDR), thyroid hormone receptor (TR), and retinoid X receptor beta (RXR beta) binding to vitamin D response elements (VDREs), two thyroid hormone response elements (TREs) (DR4 and F2), and a retinoic acid response element (DR5). VDR/RXR bound well to the VDREs and to DR4 and DR5 using the electrophoretic mobility shift assay. Surprisingly, VDR/RXR also bound well to F2, which contains half-sites arranged as an inverted palindrome. In co-transfection experiments using CV-1 cells, we observed that VDR repressed basal transcription in the absence of ligand on DR3 and osteopontin VDREs and F2, but had no effect on DR4 or DR5. VDR selectively mediated ligand-dependent transcription on only VDREs. VDR also exhibited dominant negative activity as it blocked triiodothyronine (T3)-mediated transcriptional activity on DR4 and F2. These results demonstrate that VDR/RXR heterodimers can bind promiscuously to a wide range of hormone response elements, including inverted palindromes. Moreover, they show that unliganded VDRs, similar to TRs and retinoic acid receptors, can repress basal transcription. Last, they also suggest a novel repressor function of VDR on T3-mediated transcription which may be significant in tissues where VDR and TR are co-expressed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631908     DOI: 10.1074/jbc.271.18.10910

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Functionality of unliganded VDR in breast cancer cells: repressive action on CYP24 basal transcription.

Authors:  Fatouma Alimirah; Avani Vaishnav; Michael McCormick; Ibtissam Echchgadda; Bandana Chatterjee; Rajendra G Mehta; Xinjian Peng
Journal:  Mol Cell Biochem       Date:  2010-05-04       Impact factor: 3.396

2.  Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice.

Authors:  Y Sakai; J Kishimoto; M B Demay
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic acid (CD3254).

Authors:  Peter W Jurutka; Ichiro Kaneko; Joanna Yang; Jaskaran S Bhogal; Johnathon C Swierski; Christa R Tabacaru; Luis A Montano; Chanh C Huynh; Rabia A Jama; Ryan D Mahelona; Joseph T Sarnowski; Lisa M Marcus; Alexis Quezada; Brittney Lemming; Maria A Tedesco; Audra J Fischer; Said A Mohamed; Joseph W Ziller; Ning Ma; Geoffrey M Gray; Arjan van der Vaart; Pamela A Marshall; Carl E Wagner
Journal:  J Med Chem       Date:  2013-11-01       Impact factor: 7.446

4.  Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression.

Authors:  Akiko Saito-Hakoda; Akira Uruno; Atsushi Yokoyama; Kyoko Shimizu; Rehana Parvin; Masataka Kudo; Takako Saito-Ito; Ikuko Sato; Naotaka Kogure; Dai Suzuki; Hiroki Shimada; Takeo Yoshikawa; Ikuma Fujiwara; Hiroyuki Kagechika; Yasumasa Iwasaki; Shigeo Kure; Sadayoshi Ito; Akira Sugawara
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

5.  Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB).

Authors:  Peter W Jurutka; Orsola di Martino; Sabeeha Reshi; Sanchita Mallick; Zhela L Sabir; Lech J P Staniszewski; Ankedo Warda; Emma L Maiorella; Ani Minasian; Jesse Davidson; Samir J Ibrahim; San Raban; Dena Haddad; Madleen Khamisi; Stephanie L Suban; Bradley J Dawson; Riley Candia; Joseph W Ziller; Ming-Yue Lee; Chang Liu; Wei Liu; Pamela A Marshall; John S Welch; Carl E Wagner
Journal:  Int J Mol Sci       Date:  2021-11-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.